Some kratom vendors reuse old lab results across multiple product batches because proper third-party testing costs $279 or more per sample, and the industry lacks strict federal oversight requiring batch-specific certificates of analysis. This practice puts consumers at risk because kratom's natural variability means one clean test doesn't guarantee the next batch is free from contaminants like salmonella, heavy metals, or dangerous levels of bacteria. Batch-specific testing is the gold standard, and anything less should raise a red flag.
Here's something that doesn't get talked about enough in the kratom community. You've probably seen vendors proudly displaying lab results on their websites, and you feel reassured. You think, "Great, this company tests its products." But have you ever checked the date on that certificate of analysis? Have you ever compared the batch number on the lab report to the batch number on the bag you just received? Most people haven't. And honestly, that's exactly what some vendors are banking on.
The kratom market has exploded. Over 15 million Americans now use kratom products regularly, and online extract sales alone account for more than 53% of the total market. With that kind of growth comes an uncomfortable truth: not every vendor is keeping pace with quality control. The demand for kratom is outrunning the infrastructure needed to keep it safe, and testing shortcuts are one of the most common ways vendors cut corners. Reusing lab results might sound like a minor paperwork issue, but it's actually one of the biggest red flags in the entire industry. When a vendor slaps an old COA onto a new batch, they're essentially telling you, "Trust us, it's probably fine." Probably it isn't good enough when we're talking about what goes into your body.
This matters even more when you consider kratom's history with contamination. Back in 2018, a massive Salmonella outbreak tied to kratom sickened 199 people across 41 states, with roughly a third requiring hospitalization. More recently, in late 2025, Monarch Premium Kratom products were recalled after Florida's Department of Agriculture found Salmonella contamination in finished products. These aren't hypothetical risks. They're documented, real-world consequences of inadequate testing.
Before diving into why vendors reuse these documents, it helps to understand what a COA is. A Certificate of Analysis is a laboratory report issued by an independent testing facility that documents the results of specific tests performed on a particular batch of product. That last part is critical, a particular batch. A COA is batch-, time-, and method-specific, meaning it applies only to the exact lot tested at the time it was tested, using the methods described in the report. It's not a blanket guarantee. It's not a marketing badge. It's a snapshot of one sample under defined conditions.
A thorough kratom COA typically includes several sections that consumers should understand. The sample information section identifies the product name, lot or batch number, and the collection, receipt, and reporting dates. Then there's the alkaloid analysis, which reports concentrations of key compounds such as mitragynine (usually 0.5% to 1.5% in legitimate products) and 7-hydroxymitragynine. Microbiological screening tests for organisms such as E. coli, Salmonella, yeast, and mold. Heavy metal testing screens for arsenic, lead, cadmium, and mercury. A good COA ties all this data back to a single batch with a unique identifier; without that, there's no traceability, and the document is essentially meaningless.
It's worth understanding what "ND" means on a report, too. "Not Detected" doesn't mean a substance is completely absent; it means the compound, if present, falls below the laboratory's limit of detection. Many COAs list both LOD (limit of detection) and LOQ (limit of quantitation), and knowing these limits is essential for accurately interpreting trace-level results.
So why do some vendors take the shortcut? It comes down to money, convenience, and the fact that nobody's really stopping them.
Let's talk numbers. A full FDA-panel lab test for a single kratom sample starts around $279 at labs like Wonderland Labs, one of the most well-known testing facilities in the industry. That covers biologicals, alkaloid identification, and heavy metals. Need express results in three days? That jumps to $329 per sample. Individual tests can be ordered separately, $89 for biological contaminants, $99 for alkaloid quantification, and $99 for heavy metals, but most legitimate operations run the full panel.
Now multiply that across every batch. A vendor receiving multiple shipments per month, each potentially containing dozens of different strains and products, could easily incur thousands of dollars in testing costs. For small operators running on thin margins, that's a significant expense. Some vendors do it anyway because they understand it's the cost of doing business responsibly. Others look at that line item and decide that one clean test should cover them for a while. The math tempts them, and without anyone checking, many give in.
The kratom industry operates in a regulatory gray zone. Kratom isn't FDA-approved for any use, and the agency primarily issues consumer warnings rather than enforcing testing standards across the board. The DEA keeps kratom under review without scheduling it as a controlled substance. This means there's no federal mandate requiring every kratom vendor to test every batch, leaving compliance largely voluntary.
Some states have started filling that gap. Utah, for example, requires that any COA submitted for kratom product registration come from a third-party laboratory with ISO 17025:2017 accreditation, include the lot or batch identification number matching the product, and be performed within the last six months. Florida's SB 994 is pushing similar requirements, mandating testing, FDA registration for processors, and adverse event reporting. But these are the exceptions, not the rule. In most states, vendors operate with minimal oversight, and the decision to test (or not test) every batch is entirely up to them.
Some vendors adulterate or dilute their products with cheaper substances specifically to increase profit margins, and skipping batch-specific testing makes that easier to conceal. If a vendor tests one clean batch and then reuses that COA for subsequent batches that may contain fillers or lower-quality material, the old lab report provides cover. It looks legitimate on the surface. Customers see a COA and feel satisfied. The vendor saves money on testing and potentially on raw materials. Everyone's happy, until someone gets sick.
Budget kratom can sell for as little as $80 per kilogram, while GMP-certified vendors with transparent testing typically charge $100 to $150 per kilogram or more. That price difference often reflects the cost of rigorous, batch-level testing. When a vendor's pricing seems too good to be true, it frequently indicates compromised quality or skipped testing protocols.
This isn't just a paperwork problem. Reusing COAs creates genuine safety risks that consumers need to understand.
Kratom is a botanical product, and its composition varies significantly due to growing conditions, harvest timing, drying and processing methods, and storage and handling practices. A COA from one batch simply cannot guarantee anything about the next batch, even if the product carries the same strain name. Indonesian suppliers, where the vast majority of kratom originates, don't always follow procedures that ensure uniformity across shipments. Boxes within the same shipment may contain kratom milled on different days, from different sources, with varying levels of freshness.
There's also the issue of bacterial "hot spots." Herbal powders aren't perfectly homogeneous, so a sample taken from one area of a batch might pass lab testing while a sample from another area of the same batch could fail. Unless the powder is properly blended before sampling, a single-section test can provide a dangerously incomplete picture. This is why approximately 15 to 25% of all kratom entering the United States fails microbial testing standards. That's a staggering failure rate, underscoring why every single batch needs its own lab work.
The consequences of skipping batch testing aren't theoretical. The 2018 Salmonella outbreak linked to kratom was one of the largest botanical contamination events in recent U.S. history, involving multiple Salmonella strains, including S. Javiana, S. Okatie, and S. Thompson. The CDC initially identified 132 confirmed cases, which rose to 199 infected individuals across 41 states. Roughly one-third of those with available information required hospitalization. The investigation was unable to identify a single common source; contaminated products were spread across multiple brands and suppliers.
The FDA issued its first-ever mandatory recall for a food product during that outbreak, forcing Triangle Pharmanaturals to pull all powdered kratom from its inventory after the company refused voluntary compliance. Years later, recalls continue. In 2025, Vanguard Enterprises recalled multiple Monarch Premium Kratom products after Florida authorities detected Salmonella in finished goods. These incidents demonstrate that contamination isn't a one-time fluke; it's an ongoing risk in a supply chain that spans thousands of miles from Southeast Asian farms to American consumers.
Reused COAs sometimes accompany inflated potency claims. Some brands have posted lab reports claiming 2.5% mitragynine content, which testing data from multiple labs indicates is highly unlikely for standard kratom leaf; the realistic range sits between 0.5% and 1.5%, consistent with published research. When a vendor reuses a favorable lab report or fabricates one entirely, consumers can't make informed dosing decisions. They may take less product expecting higher potency, or worse, receive product that's been adulterated with synthetic compounds to match inflated claims.
Knowing the red flags is your best defense. Here's what to watch for, and don't be shy about investigating before you buy.
COAs older than six months
The same COA is used for multiple batches or products.
No batch numbers on the COA, or batch numbers that don't match your product label
Testing only for alkaloids while skipping contaminants like heavy metals and microbials
In-house testing instead of independent third-party labs
Blurry, incomplete, or poorly formatted certificates
Generic lab reports without specific lot identification
No laboratory contact information or accreditation details on the certificate
Unusually high alkaloid percentages (above 2%) without extraction
Start by matching the batch or lot number on your product packaging to the batch number listed on the COA. If there's no match, or worse, no batch number at all, that's a dealbreaker. Double-check the testing date. A COA from a year ago is irrelevant to the product you're holding today. Utah's regulatory framework sets a six-month limit, which is a reasonable benchmark for any consumer to adopt.
Look at the laboratory information. A legitimate lab will display its company letterhead, full contact details, including physical address and phone number, and accreditation credentials. ISO 17025:2017 accreditation is the standard to aim for; it can be independently verified by accreditation bodies like PJLA. Some labs now include QR codes on their certificates that you can scan to authenticate the report directly, adding another layer of verification that makes tampering much harder.
Check whether the COA covers a full testing panel. After the 2018 Salmonella crisis, some vendors began posting COAs that tested only for Salmonella, not for anything else. A comprehensive COA should include, at a minimum, microbial screening (Salmonella, E. coli, coliforms, yeast, and mold), heavy metal testing, and alkaloid content testing. If a report only shows one or two of these panels, the vendor is likely cutting corners.
Batch number | Missing or doesn't match product | Matches product label exactly |
Testing date | Often months or years old | Recent, within weeks of sale |
Relevance to product | Reflects a different batch | Directly tied to what you purchased |
Contamination assurance | None for current batch | Verified for the specific lot |
Alkaloid accuracy | May not reflect actual potency | Reflects tested sample's true content |
Traceability | Broken chain of custody | Full traceability from sample to shelf |
QR code verification | Rarely included | Increasingly common among quality vendors |
Regulatory compliance | Fails state requirements like Utah's | Meets emerging regulatory standards |
Some kratom vendors reuse old lab results across multiple product batches because proper third-party testing costs $279 or more per sample, and the industry lacks strict federal oversight requiring batch-specific certificates of analysis. This practice puts consumers at risk because kratom's natural variability means one clean test doesn't guarantee the next batch is free from contaminants like salmonella, heavy metals, or dangerous levels of bacteria. Batch-specific testing is the gold standard, and anything less should raise a red flag.
Here's something that doesn't get talked about enough in the kratom community. You've probably seen vendors proudly displaying lab results on their websites, and you feel reassured. You think, "Great, this company tests its products." But have you ever checked the date on that certificate of analysis? Have you ever compared the batch number on the lab report to the batch number on the bag you just received? Most people haven't. And honestly, that's exactly what some vendors are banking on.
The kratom market has exploded. Over 15 million Americans now use kratom products regularly, and online extract sales alone account for more than 53% of the total market. With that kind of growth comes an uncomfortable truth: not every vendor is keeping pace with quality control. The demand for kratom is outrunning the infrastructure needed to keep it safe, and testing shortcuts are one of the most common ways vendors cut corners. Reusing lab results might sound like a minor paperwork issue, but it's actually one of the biggest red flags in the entire industry. When a vendor slaps an old COA onto a new batch, they're essentially telling you, "Trust us, it's probably fine." Probably it isn't good enough when we're talking about what goes into your body.
This matters even more when you consider kratom's history with contamination. Back in 2018, a massive Salmonella outbreak tied to kratom sickened 199 people across 41 states, with roughly a third requiring hospitalization. More recently, in late 2025, Monarch Premium Kratom products were recalled after Florida's Department of Agriculture found Salmonella contamination in finished products. These aren't hypothetical risks. They're documented, real-world consequences of inadequate testing.
Before diving into why vendors reuse these documents, it helps to understand what a COA is. A Certificate of Analysis is a laboratory report issued by an independent testing facility that documents the results of specific tests performed on a particular batch of product. That last part is critical, a particular batch. A COA is batch-, time-, and method-specific, meaning it applies only to the exact lot tested at the time it was tested, using the methods described in the report. It's not a blanket guarantee. It's not a marketing badge. It's a snapshot of one sample under defined conditions.
A thorough kratom COA typically includes several sections that consumers should understand. The sample information section identifies the product name, lot or batch number, and the collection, receipt, and reporting dates. Then there's the alkaloid analysis, which reports concentrations of key compounds such as mitragynine (usually 0.5% to 1.5% in legitimate products) and 7-hydroxymitragynine. Microbiological screening tests for organisms such as E. coli, Salmonella, yeast, and mold. Heavy metal testing screens for arsenic, lead, cadmium, and mercury. A good COA ties all this data back to a single batch with a unique identifier; without that, there's no traceability, and the document is essentially meaningless.
It's worth understanding what "ND" means on a report, too. "Not Detected" doesn't mean a substance is completely absent; it means the compound, if present, falls below the laboratory's limit of detection. Many COAs list both LOD (limit of detection) and LOQ (limit of quantitation), and knowing these limits is essential for accurately interpreting trace-level results.
So why do some vendors take the shortcut? It comes down to money, convenience, and the fact that nobody's really stopping them.
Let's talk numbers. A full FDA-panel lab test for a single kratom sample starts around $279 at labs like Wonderland Labs, one of the most well-known testing facilities in the industry. That covers biologicals, alkaloid identification, and heavy metals. Need express results in three days? That jumps to $329 per sample. Individual tests can be ordered separately, $89 for biological contaminants, $99 for alkaloid quantification, and $99 for heavy metals, but most legitimate operations run the full panel.
Now multiply that across every batch. A vendor receiving multiple shipments per month, each potentially containing dozens of different strains and products, could easily incur thousands of dollars in testing costs. For small operators running on thin margins, that's a significant expense. Some vendors do it anyway because they understand it's the cost of doing business responsibly. Others look at that line item and decide that one clean test should cover them for a while. The math tempts them, and without anyone checking, many give in.
The kratom industry operates in a regulatory gray zone. Kratom isn't FDA-approved for any use, and the agency primarily issues consumer warnings rather than enforcing testing standards across the board. The DEA keeps kratom under review without scheduling it as a controlled substance. This means there's no federal mandate requiring every kratom vendor to test every batch, leaving compliance largely voluntary.
Some states have started filling that gap. Utah, for example, requires that any COA submitted for kratom product registration come from a third-party laboratory with ISO 17025:2017 accreditation, include the lot or batch identification number matching the product, and be performed within the last six months. Florida's SB 994 is pushing similar requirements, mandating testing, FDA registration for processors, and adverse event reporting. But these are the exceptions, not the rule. In most states, vendors operate with minimal oversight, and the decision to test (or not test) every batch is entirely up to them.
Some vendors adulterate or dilute their products with cheaper substances specifically to increase profit margins, and skipping batch-specific testing makes that easier to conceal. If a vendor tests one clean batch and then reuses that COA for subsequent batches that may contain fillers or lower-quality material, the old lab report provides cover. It looks legitimate on the surface. Customers see a COA and feel satisfied. The vendor saves money on testing and potentially on raw materials. Everyone's happy, until someone gets sick.
Budget kratom can sell for as little as $80 per kilogram, while GMP-certified vendors with transparent testing typically charge $100 to $150 per kilogram or more. That price difference often reflects the cost of rigorous, batch-level testing. When a vendor's pricing seems too good to be true, it frequently indicates compromised quality or skipped testing protocols.
This isn't just a paperwork problem. Reusing COAs creates genuine safety risks that consumers need to understand.
Kratom is a botanical product, and its composition varies significantly due to growing conditions, harvest timing, drying and processing methods, and storage and handling practices. A COA from one batch simply cannot guarantee anything about the next batch, even if the product carries the same strain name. Indonesian suppliers, where the vast majority of kratom originates, don't always follow procedures that ensure uniformity across shipments. Boxes within the same shipment may contain kratom milled on different days, from different sources, with varying levels of freshness.
There's also the issue of bacterial "hot spots." Herbal powders aren't perfectly homogeneous, so a sample taken from one area of a batch might pass lab testing while a sample from another area of the same batch could fail. Unless the powder is properly blended before sampling, a single-section test can provide a dangerously incomplete picture. This is why approximately 15 to 25% of all kratom entering the United States fails microbial testing standards. That's a staggering failure rate, underscoring why every single batch needs its own lab work.
The consequences of skipping batch testing aren't theoretical. The 2018 Salmonella outbreak linked to kratom was one of the largest botanical contamination events in recent U.S. history, involving multiple Salmonella strains, including S. Javiana, S. Okatie, and S. Thompson. The CDC initially identified 132 confirmed cases, which rose to 199 infected individuals across 41 states. Roughly one-third of those with available information required hospitalization. The investigation was unable to identify a single common source; contaminated products were spread across multiple brands and suppliers.
The FDA issued its first-ever mandatory recall for a food product during that outbreak, forcing Triangle Pharmanaturals to pull all powdered kratom from its inventory after the company refused voluntary compliance. Years later, recalls continue. In 2025, Vanguard Enterprises recalled multiple Monarch Premium Kratom products after Florida authorities detected Salmonella in finished goods. These incidents demonstrate that contamination isn't a one-time fluke; it's an ongoing risk in a supply chain that spans thousands of miles from Southeast Asian farms to American consumers.
Reused COAs sometimes accompany inflated potency claims. Some brands have posted lab reports claiming 2.5% mitragynine content, which testing data from multiple labs indicates is highly unlikely for standard kratom leaf; the realistic range sits between 0.5% and 1.5%, consistent with published research. When a vendor reuses a favorable lab report or fabricates one entirely, consumers can't make informed dosing decisions. They may take less product expecting higher potency, or worse, receive product that's been adulterated with synthetic compounds to match inflated claims.
Knowing the red flags is your best defense. Here's what to watch for, and don't be shy about investigating before you buy.
COAs older than six months
The same COA is used for multiple batches or products.
No batch numbers on the COA, or batch numbers that don't match your product label
Testing only for alkaloids while skipping contaminants like heavy metals and microbials
In-house testing instead of independent third-party labs
Blurry, incomplete, or poorly formatted certificates
Generic lab reports without specific lot identification
No laboratory contact information or accreditation details on the certificate
Unusually high alkaloid percentages (above 2%) without extraction
Start by matching the batch or lot number on your product packaging to the batch number listed on the COA. If there's no match, or worse, no batch number at all, that's a dealbreaker. Double-check the testing date. A COA from a year ago is irrelevant to the product you're holding today. Utah's regulatory framework sets a six-month limit, which is a reasonable benchmark for any consumer to adopt.
Look at the laboratory information. A legitimate lab will display its company letterhead, full contact details, including physical address and phone number, and accreditation credentials. ISO 17025:2017 accreditation is the standard to aim for; it can be independently verified by accreditation bodies like PJLA. Some labs now include QR codes on their certificates that you can scan to authenticate the report directly, adding another layer of verification that makes tampering much harder.
Check whether the COA covers a full testing panel. After the 2018 Salmonella crisis, some vendors began posting COAs that tested only for Salmonella, not for anything else. A comprehensive COA should include, at a minimum, microbial screening (Salmonella, E. coli, coliforms, yeast, and mold), heavy metal testing, and alkaloid content testing. If a report only shows one or two of these panels, the vendor is likely cutting corners.
--- Canonical: https://www.kratomtest.org/blog/why-some-kratom-vendors-reuse-lab-results